53 research outputs found
The Length and Flexibility of the 2-Substituent of 9-Ethyladenine Derivatives Modulate Affinity and Selectivity for the Human A2A Adenosine Receptor
The A2A adenosine receptor (A2A AR) is a key target for the development of pharmacological tools for the treatment of central nervous system disorders. Previous works have demonstrated that the insertion of substituents at various positions on adenine leads to A2A AR antagonists with affinity in the micromolar to nanomolar range. In this work, a series of 9-ethyladenine derivatives bearing phenylalkylamino, phenylakyloxy or phenylakylthio groups of different lengths at the 2-position were synthesised and tested against the human adenosine receptors. The derivatives showed sub-micromolar affinity for these membrane proteins. The further introduction of a bromine atom at the 8-position has the effect of improving the affinity and selectivity for all ARs and led to compounds that are able bind to the A2A AR subtype at low nanomolar levels. Functional studies confirmed that the new adenine derivatives behave as A2A AR antagonists with half-maximal inhibitory concentration values in the nanomolar range. Molecular modelling studies provide a description of the possible binding mode of these compounds at the A2A AR and an interpretation of the affinity data at this AR subtype
Bestandsaufnahme von Ausbildungsinhalten zur Evidence-basierten Praxis für Biomedizinische Analytik im D-A-CH-Raum [Bericht über Entwicklungsprozess]
Adaptierung des Mustercurriculums Patientensicherheit der WHO für die Ausbildung in Biomedizinischer Analytik im DACH-Raum
Adaptierung eines EbLp-Curriculums für die Ausbildung in Biomedizinischer Analytik im DACHRaum - eine Umsetzung des DNEbM-Kerncurriculums
Evidence-basierte Laborpraxis in der Biomedizinischen Analytik praxisrelevant lernen und lehren - die CanMEDS-Rollen Scholar und Communicator in der COVID-19-Pandemie
Verifizierung eines Rollenkompetenzrahmens für die Biomedizinische Analytik im DACH-Raum und Transformation in die Ausbildung und die Berufspraxis
Zur Entwicklung von Entrustable Professional Activities (EPAs) in der biomedizinischen Laboranalytik
9-Ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution result in distinct selectivities.
9-Ethyladenine was used as the basis for a series of non-xanthine adenosine receptor antagonists at human adenosine receptors. The adenine-based compounds were substituted in 2- or 8-position with a variety of side chains including some aryl or arylalkynyl groups previously tested as 2-substituents in adenosine and 5′-N-ethylcarboxamidoadenosine (NECA) for their effect on agonist affinity. The affinity of the novel compounds was tested in radioligand binding assays (A1, A2A and A3) and inhibition of NECA-stimulated adenylyl cyclase activity (A2B) in membranes prepared from CHO cells stably transfected with the respective human receptor subtype. High affinity antagonists were identified for A1 (9-ethyl-8-phenyl-9H-adenine, compound2; 6-(1-butylamino)-9-ethyl-8-phenyl-9H-purine, compound 3), A2A (8-ethoxy-9-ethyladenine; compound 8) and A3 (9-ethyl-8-phenylethynyl-9H-adenine, compound 5) with selectivities versus other receptor subtypes in the range of 10 to 600. These results demonstrate that adenine is a useful template for further development of high-affinity antagonists with distinct receptor selectivity profiles
Synthesis, biological studies and molecular modeling investigation of 1,3-dimethyl-2,4-dioxo-6-methyl-8-(substituted) 1,2,3,4-tetrahydro [1,2,4]-triazolo [3,4-f]-purines as potential adenosine receptor antagonists
A new series of potential adenosine receptor antagonists with a [1,2,4]-triazolo-[3,4-f]-purine structure have been synthesized, and their affinities at the four adenosine receptor subtypes (A1, A2A, A2B and A3) have been evaluated. The design was based on the demonstrated approach to novel A3 adenosine receptor antagonists of adding a third ring to the xanthine structure. Unfortunately, all the synthesized compds. were completely inactive at all four adenosine receptor subtypes independently of their substitutions. Preliminary mol. modeling investigation has demonstrated that only a low degree of steric and electrostatic complementarity has been obsd. for all the new synthesized triazolo-purines with respect to other structurally related A3 receptor antagonists. This anal. yielded valuable information about structure-activity relationships and further design of potential adenosine receptor antagonist
- …